z-logo
Premium
Role of vascular reactive oxygen species in regulating cytochrome P450‐4A enzyme expression in Dahl salt‐sensitive rats
Author(s) -
Lukaszewicz Kathleen M.,
Paudyal Mahesh P.,
Falck John R.,
Lombard Julian H.
Publication year - 2016
Publication title -
microcirculation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 83
eISSN - 1549-8719
pISSN - 1073-9688
DOI - 10.1111/micc.12304
Subject(s) - oxidative stress , reactive oxygen species , chemistry , endothelial dysfunction , enzyme , medicine , superoxide , endocrinology , superoxide dismutase , blot , biochemistry , pharmacology , biology , gene
Abstract Objective The potential contribution of CYP4A enzymes to endothelial dysfunction in Dahl salt‐sensitive rats was determined by comparison to SS‐5 BN consomic rats having chromosome 5 carrying CYP4A alleles from the BN rat introgressed into the SS genetic background. Methods The following experiments were performed in cerebral arteries from HS‐fed SS and SS‐5 BN rats ± the SOD inhibitor DETC and/or the superoxide scavenger Tempol: (i) endothelial function was determined via video microscopy ± acute addition of the CYP4A inhibitor DDMS or Tempol; (ii) vascular oxidative stress was assessed with DHE fluorescence ± acute addition of DDMS, l ‐NAME, or PEG‐SOD; and (iii) CYP4A protein levels were compared by western blotting. Results In DETC‐treated SS‐5 BN and HS‐fed SS rats, (i) DDMS or Tempol ameliorated vascular dysfunction, (ii) DDMS reduced vascular oxidative stress to control levels, (iii) chronic Tempol treatment reduced vascular CYP4A protein expression, and (iv) combined treatment with Tempol and l ‐NAME prevented the reduction in CYP4A protein expression in MCA of HS‐fed SS rats. Conclusion The CYP4A pathway plays a role in vascular dysfunction in SS rats and there appears to be a direct role of reduced NO availability due to salt‐induced oxidant stress in upregulating CYP4A enzyme expression.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here